SCHEMBL29407418

SCHEMBL29407418

CCN1CCc2cc(Cn3cc(C(=O)NCc4c(-n5ccc(C#N)n5)ccc(OC)c4F)c(COC)n3)ccc2C1

nearest known ligand 0.95

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ F11 P03951 13/20 0.95
▸ KLKB1 P03952 9/20 0.82

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29697529 0.98 F11 (1.00) F11KLKB1
SCHEMBL29697605 0.93 F11 (1.00) F11KLKB1
SCHEMBL22981963 0.93 F11 (1.00) F11KLKB1
SCHEMBL22982169 0.91 F11 (0.95) F11KLKB1
SCHEMBL29407429 0.91 F11 (0.95) F11KLKB1
SCHEMBL29697644 0.91 F11 (1.00) F11KLKB1
SCHEMBL22982463 0.91 F11 (1.00) F11KLKB1
SCHEMBL22981883 0.90 KLKB1 (1.00) F11KLKB1
SCHEMBL29405556 0.90 KLKB1 (1.00) F11KLKB1
SCHEMBL22981999 0.89 F11 (1.00) F11KLKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4010333-A1 PLASMA KALLIKREIN INHIBITORS Kalvista Pharmaceuticals Limited (GB) 2022-06-15 — — EP disclosed
CN-114206852-A Plasma kallikrein inhibitors 卡尔维斯塔制药有限公司 2022-03-18 — — CN disclosed
Send feedback